Electromagnetic Emissions from Wireless Power Transfer System

In this paper, the measurement and analysis of the electromagnetic radiated emissions from the wireless power transfer system is reported. The aim is to evaluate the level of the electromagnetic field produced by the magnetic resonance wireless power transfer system. Due to the advances of the wireless power transfer technology, it becomes feasible to apply the wireless power transfer in the electric vehicles charging. Among the existent wireless power transfer technologies, the magnetic resonant coupling is proven to be the most suitable for this task. Because of strong electromagnetic field generated by wireless power transfer system the electromagnetic compatibility has become an important issue.

Electric Vehicle Battery Charger: Wireless Power Transfer System Controlled by Magnetic Core Reactor

This paper presents a control process and frequency adjustment based on the magnetic core reactor for electric vehicle battery charger. Since few decades ago, there have been significant developments in technologies used in wireless power transfer systems, namely in battery charger. In the wireless power transfer systems is essential that the frequency of the primary circuit be equal to the frequency of the secondary circuit so there is the maximum energy transfer. The magnetic core reactor allows controlling the frequencies on both sides of the transmission and reception circuits. Also, the assembly diagrams and test results are presented.

Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR)

Rivastigmine is a very important drug prescribed for the treatment of Alzheimer's disease (AD) symptoms. It is a dual inhibitor, in that it inhibits both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). For our screening program on the discovery of new rivastigmine analogue hits for human butyrylcholinesterase (hBuChE) inhibition, we investigated the interaction of this inhibitor with BuChE using the complimentary approach of the biophysical method, saturation transfer difference (STD)-NMR and molecular docking. This allowed us to obtain essential information on the key binding interactions between the inhibitor and the enzyme to be used for screening of hit compounds. The main conclusions obtained from this integrated study was that the most dominant interactions were (a) H-bonding between the carbamate carbonyl of the inhibitor and the NH group of the imidazole unit of H434, (b) stacking of the aromatic unit of the inhibitor and the W82 aromatic unit in the choline binding pocket via pi-pi interactions and (c) possible CH/pi interactions between the benzylic methyl group and the N-methyl groups of the inhibitor and W82 of the enzyme.